Healthcare
-
Should investors bear with US?
Paul O’Connor of Janus Henderson and T Rowe Price’s Eric Papesh give their views on the prospects for American assets
-
How to spot the US small-cap stars
This inherently innovative but sometimes esoteric sector has a lot to offer but market conditions are getting choppy
-
Five themes taking centre-stage for ESG investors
Investing through a thematic lens is vital if we are to realise a sustainable world. Portfolio Adviser’s sister publication ESG Clarity talks to experts about the challenges and opportunities in five key areas
-
Property funds fare worst in a sorry September for investors
While US bonds, healthcare and Latin America deliver the only bright spots
-
Investing in personalised medicine: One step forward, two steps back
Patients may prefer to stay on existing treatments and wait 10-to-20 years to see how the hoped-for cure is working
Search sponsored by
Sponsored Content
